BYOT.L

Byotrol Plc
Byotrol PLC - Director Dealing
2nd April 2024, 14:27
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0214J
Byotrol PLC
02 April 2024
 

Logo, company name Description automatically generated

 

 



Byotrol Plc

("Byotrol" or the "Company")

 

Director Dealing

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that, on 2nd April 2024, David Traynor, Interim CEO of the Company, purchased a total of 2,808,326 ordinary shares of 0.25p each ("Ordinary Shares") at an average price of 0.134p per Ordinary Share (the "Purchase").

 

Following the Purchase, Mr. Traynor's beneficial holding is 12,743,623 Ordinary Shares, representing 2.8% of the total voting rights of the Company. As announced on 28 July 2022, Mr. Traynor subscribed for convertible loan notes in the Company, which if converted would represent an additional 0.34% of the total voting rights of the Company.

 

 

For further information contact:

 

Byotrol Plc


Dr Trevor Francis, Non- Executive Chairman

+44 (0)1925 742 000

David Traynor, Interim Chief Executive Officer

Chris Sedwell, Chief Financial Officer

 




Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Geoff Nash/George Dollemore - Corporate Finance

Nigel Birks/Harriet Ward - ECM






Flagstaff Strategic and Investor Communications

+44 (0)20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon                                          

 

byotrol@flagstaffcomms.com

 

 

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the animal and human healthare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Traynor

2.               

Reason for the Notification

a)

Position/status

Interim Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol plc

b)

LEI

213800AJMTSTIPA59A34

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.25 pence per share

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.134p

2,808,326

d)

Aggregated information:

·Aggregated volume

· Price

 

See 4c) above

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

AIM, London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGGDDZDGDZM]]>
TwitterFacebookLinkedIn